Seller record · Telehealth service

ElleS

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: No page states that a compounded drug is not FDA-approved. The only compounding statement is that the company does not manufacture compounded medications, and the product panels, terms and consent pages carry no approval statement. 1 more criterion also fails; see the table below.

At a glance

ElleSTelehealth service

6/8criteria passed

Price: Semaglutide injection from $269 a month, tirzepatide injection from $359
Sells: semaglutide injection, tirzepatide injection, semaglutide oral capsules, and 7 more
FDA letters: None on file

Visit ElleS See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service for women selling compounded semaglutide and tirzepatide as injections, oral capsules and microdose plans, with NAD+, sermorelin, glutathione and PT-141. It prints starting monthly prices and names four filling pharmacies, and no page states that a compounded drug is not FDA-approved.

Operating entity ElleS Care LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	ElleS' website
S2	Prescription gating	PASS	ElleS' intake site; ElleS' website
S3	Pharmacy identification	PASS	ElleS' website
S4	Compounding disclosure	FAIL	ElleS' website; ElleS' weight loss category page; ElleS' terms of service page; ElleS' medical consent page
S5	Analytical documentation	FAIL	ElleS' weight loss category page; ElleS' longevity category page
S6	Business address	PASS	ElleS' terms of service page; ElleS' privacy policy
S7	Price disclosure	PASS	ElleS' weight loss category page; ElleS' longevity category page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each assessment and medication is issued only when clinically appropriate, and the medical team is named as Lion MD, led by two physicians printed with their NPI numbers.Source: ElleS' website.

S2PASSThe start button opens a seven-step assessment whose first screen asks for the buyer's basic details, and the home page describes a clinician review and approval before any medication ships.Source: ElleS' intake site; ElleS' website.

S3PASSFour filling pharmacies are named with telephone numbers and web addresses: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx. No street address is printed for any of the four.Source: ElleS' website.

S4FAILNo page states that a compounded drug is not FDA-approved. The only compounding statement is that the company does not manufacture compounded medications, and the product panels, terms and consent pages carry no approval statement.Source: ElleS' website; ElleS' weight loss category page; ElleS' terms of service page; ElleS' medical consent page.

S5FAILNo certificate of analysis or lot document is published on the category pages, the product panels or the legal pages.Source: ElleS' weight loss category page; ElleS' longevity category page.

S6PASSElleS Care LLC at 1665 Bedford Ave, Suite 1, Brooklyn, NY 11225, printed with a telephone number in the terms, the privacy policy, the privacy practices and the medical consent.Source: ElleS' terms of service page; ElleS' privacy policy.

S7PASSEach product prints a starting monthly price for its longest plan, and no price for a shorter plan is printed beside it: semaglutide injection from $269 a month, tirzepatide injection from $359, oral semaglutide capsules from $299, oral tirzepatide capsules from $349, microdose semaglutide from $179 and microdose tirzepatide from $199. NAD+ as an injection, nasal spray or tablets and sermorelin as an injection or tablets from $249 a month, glutathione from $109 and PT-141 from $199.Source: ElleS' weight loss category page; ElleS' longevity category page.

S8PASSNo FDA warning letter names ElleS or ElleS Care LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, semaglutide oral capsules, tirzepatide oral capsules, microdose semaglutide ODT and injection, microdose tirzepatide ODT and injection, NAD+ injection, nasal spray and tablets, sermorelin injection and ODT, glutathione, PT-141 injection.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141

Visit ElleS

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.